MD, MSc, FRCP
Dr. Lawson is a pediatric endocrinologist at the Children’s Hospital of Eastern Ontario (CHEO), Associate Professor of Pediatrics at the University of Ottawa, and Senior Scientist in the Evidence to Practice Research Program of the CHEO Research Institute. Her diabetes research focusses on type 1 diabetes in children and youth, its prevention and its management, particularly the use of technologies such as insulin pump therapy and continuous glucose monitoring (CGM). She is the Principal Investigator of the JDRF CCTN funded multicentre CGM TIME Trial – Timing of Initiation of Continuous Glucose Monitoring in Established Pediatric Diabetes. This randomized controlled trial is comparing simultaneous initiation of CGM and insulin pump therapy to standard pump therapy with delayed addition of CGM in pump naïve children and adolescents. As Director of CHEO’s JDRF CCTN Centre for Type 1 Diabetes Research, Dr. Lawson also leads CHEO’s involvement in two other JDRD CCTN studies – the Transition Study and CD-DIET. In addition, Dr. Lawson leads the Coordinating Centre for TRIGR Canada (Trial to Reduce IDDM in the Genetically atRisk) and the TRIGR Ottawa Clinical Site, and is deputy principal investigator for TRIGR Canada. TRIGR is an international multicentre trial evaluating whether early infant nutrition can prevent or delay the risk of type 1 diabetes in genetically susceptible children.